JPRN-UMIN000028252已完成2 期
Phase II trial of neoadjuvant docetaxel + cisplatin + fluorouracil (DCF) therapy for esophageal cancer - Phase II trial of neoadjuvant docetaxel + cisplatin + fluorouracil (DCF) therapy for esophageal cancer
agoya University0 个研究点目标入组 28 人开始时间: 2017年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Clear T4 other than invasion of cervical / cervical gastrointestinal tract esophageal cancer 2) Distant metastasis to other than supraclavicular lymph nodes. 3) Esophagogastric junction lesion of which main lesion is located in the stomach rather than the esophagus. 4) Judged not to be eligible by the researchers
研究者
相似试验
已完成
2 期
A phase II study of neoadjuvant docetaxel/cyclophosphamide (DC) followed by epirubicin/cyclophosphamide (EC) for triple-negative breast cancerbreast cancerJPRN-UMIN000011031Tokyo Women's Medical University34
Unknown
2 期
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal CancerNasopharyngeal CarcinomaNCT01614938Fudan University46
已完成
不适用
Phase II trial of docetaxel+cisplatin+capecitabine (DCX) therapy for unresectable or recurrent HER2-negative gastric cancerGastric cancerJPRN-UMIN000026722Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital35
进行中（未招募）
2 期
eoadjuvant docetaxel, oxaliplatin and S-1 therapy for large type 3 or type 4 gastric cancerGastric cancerJPRN-jRCTs051190060GOTO Masahiro46
招募中
2 期
Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancerpatients with metastatic penile cancerJPRN-UMIN000002697Fudan University Shanghai Cancer Center40